• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

CFSAC meeting Oct 3-4, 2012

jimells

Senior Member
Messages
2,009
Location
northern Maine
It's a huge help to get 'blow-by-blow color commentary'. With my dial-up connection, I can't really access any kind of video, live or otherwise.

Do the committee members *really* understand how desparate we are? I know it's pipe dream, but if they spent even 15 minutes browsing through this forum, they would know.

I'll be astounded if the meeting accomplishes anything useful. My impression is that they are working on a plan to develop a plan to do something someday if there is any money left over after feeding the military machine. :(
 
Messages
15,786
Do the committee members *really* understand how desparate we are? I know it's pipe dream, but if they spent even 15 minutes browsing through this forum, they would know.

I'll be astounded if the meeting accomplishes anything useful. My impression is that they are working on a plan to develop a plan to do something someday if there is any money left over after feeding the military machine. :(

I think you're right somewhat, but it's looking better than past meetings I've watched. And the bureaucrats seem to be trying harder to look like they're doing something useful ("Look, we're funding jaw and pelvic studies! That counts toward ME/CFS"), and seem to be responding more to criticism, even if it's just a matter of cringing and stuttering a bit.

I think the presidential attention is helping already, and maybe they've got the incentive to make real progress now. There also seems to be more quality committee members, and fewer clueless random people that want something to add to their CV.
 
Messages
15,786
I'm also hearing a lot more "ME/CFS" than in the past, and a lot less "chronic fatigue" ... And most of the "chronic fatigue" came from a real ME researcher :p
 

Hope123

Senior Member
Messages
1,266
I think advocates would do well to inform themselves about the government and how it works but on the other hand, I feel like Dr. Maier and Dr. Lee place TOO much responsibility on patients and their families. After all, aren't they suppose to be the experts in terms of knowing which programs would help us?

My read of watching CFSAC over the years is that while there are some members who understand the urgency of our situation, many still don't get it.
 

urbantravels

disjecta membra
Messages
1,333
Location
Los Angeles, CA
Um, why are we getting a long lecture on the history of the FDA? Interesting and all (well, not to me, but I already have a good working knowledge of the history of medicine) but it's taking a lot of committee time.
 

urbantravels

disjecta membra
Messages
1,333
Location
Los Angeles, CA
Oh, hi, now we're getting an explanation about how we need biomarkers and objective measures of disease severity in order to evaluate potential treatments. News flash!

I don't want to slag on the speaker, I think she is genuinely working hard to be informative, but these are NOT issues that never occurred to the ME/CFS community. In fact I often think we talk of little else!
 

SpecialK82

Ohio, USA
Messages
993
Location
Ohio, USA
Urban - totally agree that we get too much general/historical type information in these agency updates, instead of specifically focusing the entire talk on CFS/ME
 

SOC

Senior Member
Messages
7,849
Oh, hi, now we're getting an explanation about how we need biomarkers and objective measures of disease severity in order to evaluate potential treatments. News flash!

I don't want to slag on the speaker, I think she is genuinely working hard to be informative, but these are NOT issues that never occurred to the ME/CFS community. In fact I often think we talk of little else!

We all know all these points she's making. We've been arguing that we need biomarkers forever. Is she saying that if there aren't clear biomarkers, we're just not going to get a med?
 

SOC

Senior Member
Messages
7,849
Didn't she say they don't have good measures for depression, but there's still FDA approved meds for it. Is there a discontinuity here or am I missing something?
 

urbantravels

disjecta membra
Messages
1,333
Location
Los Angeles, CA
That's true. But she did say that symptoms could be a clinical endpoint - that it wasn't *impossible* to measure them, just "complex" to do so.

In fact they're just saying that now - biomarkers are not essential and not the only measure of drug efficacy.
 

SOC

Senior Member
Messages
7,849
So is the real problem we have that we need to focus on individual symptoms to get meds approved (and on the CDC website)? For example, do we need to have clinic trials for pain meds, and other clinic trials for antivirals, and other clinical trials for GI treatments?
 

SOC

Senior Member
Messages
7,849
It sounds to me like that darned CFS label is getting in our way again. I didn't hear earlier speakers, but certainly Dr Kweder of the FDA didn't seem to understand that we have a multitude of symptoms, many of which could be measured and treated. Fatigue is not the only one, or even necessarily the most debilitating. Sure, we'd love a cure, but right today many of us would be happy with some reasonable, insurance-covered symptom treatment.

And the CDC guy had me climbing the wall. Why can't they put OI treatments on the CDC website for ME/CFS patients with OI, or antivirals for patients with documented viral infections? The list could be substantial.
 

Nielk

Senior Member
Messages
6,970
I feel that there is such a disconnect between the committee members and the public speakers.

They might as well be taken place in different rooms. Because there is no feedback or discussion back and forth, there is no way to gauge whether anyone is even paying attention to us.